---
schema_version: "secwatch.filing_event.v1"
accession: "0001567264-25-000096"
form_type: "8-K"
ticker: "INTS"
cik: "0001567264"
company_name: "INTENSITY THERAPEUTICS, INC."
filed_at: "2025-10-23T23:59:59+00:00"
generated_at: "2026-05-17T02:30:07.127013+00:00"
event_type: "other"
sentiment: "neutral"
materiality_score: 0.6
calibrated_materiality_score: 0.6
confidence: "high"
source: SEC EDGAR
---

# Intensity Therapeutics shareholders approve reverse stock split ratio of 1:5 to 1:30

## Summary
- Reverse split proposal passed with 18,333,570 For, 4,508,502 Against, 27,490 Abstain.
- Adjournment proposal also approved: 18,869,741 For, 3,893,779 Against, 106,042 Abstain.
- Quorum of 22,869,562 shares (46.61% of outstanding common stock) was present at the 10/22/2025 Special Meeting.
- Board may set the exact ratio within 1:5 to 1:30 range or abandon the split entirely.

## SEC filing metadata
- accession: 0001567264-25-000096
- form_type: 8-K
- ticker: INTS
- cik: 0001567264
- company_name: INTENSITY THERAPEUTICS, INC.
- filed_at: 2025-10-23T23:59:59+00:00
- event_type: other
- sentiment: neutral
- materiality_score: 0.6
- calibrated_materiality_score: 0.6
- confidence: high
- sec_items: 5.07
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1567264/000156726425000096/0001567264-25-000096-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1567264/000156726425000096/intensity-20251022.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001567264-25-000096
- JSON: https://secwatch.observer/filing/0001567264-25-000096.json
- Plain text: https://secwatch.observer/filing/0001567264-25-000096.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.